Package insert for Baiyunshan Cefprozil Dispersible Tablets detailing composition, dosage, warnings, and storage.
About this manual
This leaflet provides comprehensive information on Cefprozil Dispersible Tablets, including the active ingredient, chemical properties, physical appearance, and approved therapeutic indications such as upper and lower respiratory tract infections and skin infections.
It also covers dosage regimens for different age groups, adjustments for renal impairment, contraindications, possible adverse reactions, drug interactions, pharmacokinetic data, and proper storage and packaging instructions. This manual is written in Chinese.
What's inside
- Drug Name
- Composition
- Physical Description
- Indications
- Dosage and Administration
- Contraindications
- Precautions
- Adverse Reactions
- Pharmacokinetics
- Storage and Packaging
Specifications
| Active ingredient | Cefprozil |
|---|
| Strength per tablet | 0.25 g (as cefprozil) |
|---|
| Molecular formula | C18H19N3O5S·H2O |
|---|
| Molecular weight | 407.45 g/mol |
|---|
| Shelf life | 24 months |
|---|
| Storage condition | Protect from light, sealed, cool dry place ≤20 °C |
Frequently asked questions
What is the recommended dosage for adults with upper respiratory infection?
Adults (13 years and older) should take 0.5 g (2 tablets) once daily for upper respiratory tract infection.
How should the medication be stored?
Store the tablets protected from light, in a sealed container, in a cool dry place not exceeding 20 °C.
What are the common adverse reactions?
Common adverse reactions include gastrointestinal effects such as diarrhea, nausea, vomiting, abdominal pain, and allergic reactions like rash and urticaria.